Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors
Abstract Obesity among breast cancer survivors is associated with increased risk for recurrence and mortality. The hormone ghrelin plays a role in initiating appetite and thus regulating body weight. This study aims to determine the effect of a lifestyle intervention on ghrelin levels in breast canc...
Guardado en:
Autores principales: | Leah Puklin, Brenda Cartmel, Maura Harrigan, Lingeng Lu, Fang-yong Li, Tara Sanft, Melinda L. Irwin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45e297f893bf4fb1884f210c8624c2af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Maura Harrigan, et al.
Publicado: (2021) -
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
por: Cho AR, et al.
Publicado: (2020) -
The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects
por: Lopes AL, et al.
Publicado: (2013) -
The Effect of Weight-Loss Interventions on Cervical and Chin Subcutaneous Fat Depots; the CENTRAL Randomized Controlled Trial
por: Gal Tsaban, et al.
Publicado: (2021) -
Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials
por: Huang H, et al.
Publicado: (2019)